Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Antioxidant enzymes have shown promise as a therapy for pathological conditions involving increased production of reactive oxygen species (ROS). However the efficiency of their use for combating oxidative stress is dependent on the ability to achieve therapeutically adequate levels of active enzymes at the site of ROS-mediated injury. Thus, the implementation of antioxidant enzyme therapy requires a strategy enabling both guided delivery to the target site and effective protection of the protein in its active form. To address these requirements we developed magnetically responsive nanoparticles (MNP) formed by precipitation of calcium oleate in the presence of magnetite-based ferrofluid (controlled aggregation/precipitation) as a carrier for magnetically guided delivery of therapeutic proteins. We hypothesized that antioxidant enzymes, catalase and superoxide dismutase (SOD), can be protected from proteolytic inactivation by encapsulation in MNP. We also hypothesized that catalase-loaded MNP applied with a high-gradient magnetic field can rescue endothelial cells from hydrogen peroxide toxicity in culture. To test these hypotheses, a family of enzyme-loaded MNP formulations were prepared and characterized with respect to their magnetic properties, enzyme entrapment yields and protection capacity. SOD- and catalase-loaded MNP were formed with average sizes ranging from 300 to 400 nm, and a protein loading efficiency of 20-33%. MNP were strongly magnetically responsive (magnetic moment at saturation of 14.3 emu/g) in the absence of magnetic remanence, and exhibited a protracted release of their cargo protein in plasma. Catalase stably associated with MNP was protected from proteolysis and retained 20% of its initial enzymatic activity after 24h of exposure to pronase. Under magnetic guidance catalase-loaded MNP were rapidly taken up by cultured endothelial cells providing increased resistance to oxidative stress (62+/-12% cells rescued from hydrogen peroxide induced cell death vs. 10+/-4% under non-magnetic conditions). We conclude that non-polymeric MNP formed using the controlled aggregation/precipitation strategy are a promising carrier for targeted antioxidant enzyme therapy, and in combination with magnetic guidance can be applied to protect endothelial cells from oxidative stress mediated damage. This protective effect of magnetically targeted MNP impregnated with antioxidant enzymes can be highly relevant for the treatment of cardiovascular disease and should be further investigated in animal models.

[1]  Juliane Nguyen,et al.  Biodegradable polymeric nanocarriers for pulmonary drug delivery , 2008 .

[2]  D. Harrison,et al.  Oxidative stress and hypertension. , 2007, Journal of the American Society of Hypertension : JASH.

[3]  T. Aw,et al.  In-Stent Stenosis: Potential Role of Increased Oxidative Stress and Glutathione-Linked Detoxification Mechanisms , 2008, Angiology.

[4]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[5]  R. Strickley Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[6]  G. Klöppel,et al.  Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta. , 2007, Journal of the American College of Cardiology.

[7]  Conroy Sun,et al.  Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.

[8]  V. Muzykantov,et al.  Polymer nanocarriers protecting active enzyme cargo against proteolysis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Gary Friedman,et al.  High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents , 2008, Proceedings of the National Academy of Sciences.

[10]  Steven P Schwendeman,et al.  Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.

[11]  V. Muzykantov,et al.  PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide. , 2003, Free radical biology & medicine.

[12]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[13]  V. Muzykantov,et al.  Synthetic Carriers for Vascular Delivery of Protein Therapeutics , 2006, Biotechnology & genetic engineering reviews.

[14]  M. Runge,et al.  Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes , 2005, Journal of thrombosis and haemostasis : JTH.

[15]  E. Allémann,et al.  Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues , 2005, AAPS PharmSciTech.

[16]  I. Alferiev,et al.  Cholesterol-derivatized polyurethane: characterization and endothelial cell adhesion. , 2005, Journal of biomedical materials research. Part A.

[17]  T. Nagai,et al.  Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. , 2008, Journal of biomedical materials research. Part A.

[18]  Gaurav Sharma,et al.  Current approaches to stabilising and analysing proteins during microencapsulation in PLGA , 2009 .

[19]  P. Libby,et al.  Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. , 1998, Journal of lipid research.

[20]  F. Laurindo,et al.  Redox Processes Underlying the Vascular Repair Reaction , 2004, World Journal of Surgery.

[21]  Cheng-Dah Chen,et al.  Analysis of peptides and proteins affinity-bound to iron oxide nanoparticles by MALDI MS , 2007, Journal of the American Society for Mass Spectrometry.

[22]  F. Spener,et al.  Fatty acids as regulators of lipid metabolism. , 2000 .

[23]  V. Muzykantov,et al.  Platelet-Endothelial Cell Adhesion Molecule-1-Directed Endothelial Targeting of Superoxide Dismutase Alleviates Oxidative Stress Caused by Either Extracellular or Intracellular Superoxide , 2007, Journal of Pharmacology and Experimental Therapeutics.

[24]  V. Muzykantov,et al.  Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress. , 2004, Methods in molecular biology.

[25]  A. Al Haj Zen,et al.  Adenovirus-Mediated Gene Transfer of Superoxide Dismutase and Catalase Decreases Restenosis after Balloon Angioplasty , 2005, Journal of Vascular Research.

[26]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[27]  K. Rao Recent developments of collagen-based materials for medical applications and drug delivery systems. , 1995, Journal of biomaterials science. Polymer edition.

[28]  W. Mark Saltzman,et al.  Enhancement of transfection by physical concentration of DNA at the cell surface , 2000, Nature Biotechnology.

[29]  S. Bajpai,et al.  Magnetic nanoparticles for drug delivery applications. , 2008, Journal of nanoscience and nanotechnology.

[30]  D. Harrison,et al.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. , 2003, Trends in pharmacological sciences.

[31]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[32]  R. de Caterina,et al.  Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[33]  M. Soory Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. , 2009, Infectious disorders drug targets.

[34]  V. Muzykantov,et al.  Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. , 2008, Biomaterials.

[35]  R. Tilton,et al.  Poly(ethylene glycol)-Modified Proteins: Implications for Poly(lactide-co-glycolide)-Based Microsphere Delivery , 2009, The AAPS Journal.

[36]  Gary Friedman,et al.  Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  N. Porter,et al.  Mechanisms of free radical oxidation of unsaturated lipids , 1995, Lipids.